EP3288580 - GLYCAN-DEPENDENT IMMUNOTHERAPEUTIC MOLECULES [Right-click to bookmark this link] | Status | The application has been refused Status updated on 04.11.2022 Database last updated on 03.09.2024 | |
Former | Examination is in progress Status updated on 25.10.2019 | ||
Former | Request for examination was made Status updated on 02.02.2018 | ||
Former | The international publication has been made Status updated on 11.11.2016 | Most recent event Tooltip | 04.11.2022 | Refusal of application | published on 07.12.2022 [2022/49] | Applicant(s) | For all designated states The Regents of the University of California 1111 Franklin Street, 12th Floor Oakland, CA 94607 / US | [2018/10] | Inventor(s) | 01 /
DEMETRIOU, Michael 2 Twain Street Irvine, CA 92317 / US | 02 /
ZHOU, Raymond, Wenhou 6981 23rd Street Sacramento, CA 95822 / US | [2018/10] | Representative(s) | Leonard, Thomas Charles, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [2018/10] | Application number, filing date | 16789833.7 | 29.04.2016 | [2018/10] | WO2016US30113 | Priority number, date | US201562155761P | 01.05.2015 Original published format: US 201562155761 P | [2018/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016178996 | Date: | 10.11.2016 | Language: | EN | [2016/45] | Type: | A1 Application with search report | No.: | EP3288580 | Date: | 07.03.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.11.2016 takes the place of the publication of the European patent application. | [2018/10] | Search report(s) | International search report - published on: | KR | 10.11.2016 | (Supplementary) European search report - dispatched on: | EP | 26.11.2018 | Classification | IPC: | A61K38/17, A61K39/395, C07K14/00, A61K38/16, A61K48/00, A61P35/00 | [2020/27] | CPC: |
A61K38/168 (EP,KR,US);
A61K38/1732 (KR,RU);
A61K47/6849 (US);
A61K38/178 (EP);
A61K48/00 (KR);
A61P35/00 (EP,KR,RU,US);
C07K14/4726 (EP);
C07K16/2809 (EP,US);
C07K16/2851 (US);
C07K2317/24 (US);
C07K2317/31 (US);
C07K2317/622 (EP,US);
|
Former IPC [2018/10] | A61K38/17, A61K38/16, A61K48/00, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/10] | Title | German: | GLYCAN-ABHÄNGIGE IMMUNTHERAPEUTISCHE MOLEKÜLE | [2018/10] | English: | GLYCAN-DEPENDENT IMMUNOTHERAPEUTIC MOLECULES | [2018/10] | French: | MOLÉCULES IMMUNOTHÉRAPEUTIQUES DÉPENDANT DE GLYCANE | [2018/10] | Entry into regional phase | 30.11.2017 | National basic fee paid | 30.11.2017 | Search fee paid | 30.11.2017 | Designation fee(s) paid | 30.11.2017 | Examination fee paid | Examination procedure | 30.11.2017 | Examination requested [2018/10] | 30.11.2017 | Date on which the examining division has become responsible | 21.06.2019 | Amendment by applicant (claims and/or description) | 30.10.2019 | Despatch of a communication from the examining division (Time limit: M04) | 09.03.2020 | Reply to a communication from the examining division | 16.10.2020 | Despatch of a communication from the examining division (Time limit: M04) | 26.02.2021 | Reply to a communication from the examining division | 23.06.2022 | Cancellation of oral proceeding that was planned for 27.06.2022 | 27.06.2022 | Date of oral proceedings (cancelled) | 25.07.2022 | Despatch of communication that the application is refused, reason: substantive examination [2022/49] | 04.08.2022 | Application refused, date of legal effect [2022/49] | Divisional application(s) | EP22182364.4 / EP4088732 | Fees paid | Renewal fee | 27.04.2018 | Renewal fee patent year 03 | 29.04.2019 | Renewal fee patent year 04 | 27.04.2020 | Renewal fee patent year 05 | 27.04.2021 | Renewal fee patent year 06 | 27.04.2022 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]IL198479 (PROCOGNIA ISRAEL LTD [IL], et al) [X] 12,13 * page 11 * * claims 1-26 * [Y] 1-5,7-9,11,14,15; | [XYI]WO2013151649 (SIALIX INC [US]) [X] 12,13 * paragraphs [0100] , [0189] - [0190] - [0196] , [0197] * * claims 1-47 * [Y] 1-5,7-9,11,14,15 [I] 1-5,7-9,11,14,15; | [XI]WO2015054600 (SIAMAB THERAPEUTICS INC [US]) [X] 12,13 * paragraphs [0209] , [0242] , [0248] - [0272] * * claims 29-30 * [I] 1-5,7-9,11,14,15; | [XPI]WO2016057916 (SIAMAB THERAPEUTICS INC [US]) [XP] 12,13 * paragraphs [0024] - [0027] - [0177] - [0186] - [0205] - [0228] - [0318] - [0348] * [I] 1-5,7-9,11,14,15; | [E]WO2016077526 (SIAMAB THERAPEUTICS INC [US]) [E] 1-15 * claims 1-75 *; | [AP] - DANYANG FENG ET AL, "Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines", ACS CHEMICAL BIOLOGY, (20160101), vol. 11, no. 4, doi:10.1021/acschembio.6b00084, ISSN 1554-8929, pages 850 - 863, XP055428997 [AP] 1-15 * the whole document * DOI: http://dx.doi.org/10.1021/acschembio.6b00084 | International search | [A]US2006148681 (LEI HUAN-YAO [TW], et al) [A] 1-48 * See the whole document. *; | [A]US2010104572 (LURIA SYLVIE [IL]) [A] 1-48 * See abstract; claims 41-51; and paragraphs [0116]-[0154]. *; | [A]WO2011145085 (PROCOGNIA ISRAEL LTD [IL], et al) [A] 1-48 * See the whole document. *; | [A]WO2015017734 (UNIV ARKANSAS [US]) [A] 1-48* See the whole document. *; | [XA] - MEDEIROS et al., "A Tn antigen binding lectin from Myrsine coriacea displays toxicity in human cancer cell lines", Journal of Natural Medicines, (20130000), vol. 67, no. 2, pages 247 - 254, XP055328615 [X] 1-9, 19-27, 39-44, 46 * See abstract; pages 250-251; and Table 4. * [A] 10-18, 28-38, 45, 47-48 DOI: http://dx.doi.org/10.1007/s11418-012-0671-x | by applicant | US4708871 | US5350674 | US5399346 | US5580859 | US5585362 | US5589466 | US5858358 | US5883223 | US5993434 | US6103489 | US6181964 | WO0129058 | US6233482 | US6241701 | US6326193 | WO0196584 | US6352694 | US6516223 | US6534055 | US6567694 | US6678556 | US2004014645 | US6692964 | US2004059285 | US2004092907 | US2004101519 | US6797514 | US2005052630 | US6867041 | US2005070841 | US6887466 | US6905680 | US6905681 | US6905874 | US2006034810 | US2006121005 | US7067318 | US7144575 | US7171264 | US7173116 | US7172869 | US7175843 | US2007128708 | US7232566 | US2013287748 | US2014099309 | US2014271635 | US2014370017 | - STAERZ et al., Nature, (19850000), vol. 314, pages 628 - 631 | - SCOTT et al., Nat Rev Cancer, (20120000), vol. 12, pages 278 - 287 | - HAANEN et al., J. Exp. Med., (19990000), vol. 190, no. 9, page 13191328 | - HOUSTON et al., Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, pages 5879 - 5883 | - ROBERGE J Y et al., Science, (19950000), vol. 269, pages 202 - 204 | - ALTSCHUL, S. et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410 | - REEDIJK et al., The EMBO Journal, (19920000), vol. 11, no. 4, page 1365 | - ULYSSE, L. et al., J. Am. Chem. Soc., (19950000), vol. 117, pages 8466 - 8467 | - G. BARANYR. B. MERRIFIELD, The Peptides: Analysis Synthesis, Biology, Academic Press, (19800000), vol. 2, pages 3 - 254 | - CHRISTIAN et al., J. Mol. Biol., (19920000), vol. 227, page 711 | - DEVLIN et al., Science, (19900000), vol. 249, page 404 | - CWIRLA et al., Proc. Natl. Acad, Sci. USA, (19900000), vol. 87, page 6378 | - LIMBACH et al., Nucleic Acids Res., (19940000), vol. 22, pages 2183 - 2196 | - UI-TEI et al., FEBS Letters, (20000000), vol. 479, pages 79 - 82 | - GHOSH et al., Glycobiology, (19910000), vol. 5, pages 505 - 10 | - SCHENBORNMIERENDORF, Nuc Acids Res., (19850000), vol. 13, pages 6223 - 36 | - NACHEVABERZAL-HERRANZ, Eur. J. Biochem., (20030000), vol. 270, pages 1485 - 65 | - COUGOT et al., Trends in Biochem. Sci., (20010000), vol. 29, pages 436 - 444 | - STEPINSKI et al., RNA, (20010000), vol. 7, pages 1468 - 95 | - ELANGO et al., Biochim. Biophys. Res. Commun., (20050000), vol. 330, pages 958 - 966 | - NISHIKAWA et al., Hum Gene Ther., (20010000), vol. 12, no. 8, pages 861 - 70 | - LIU et al., Cell, (19910000), vol. 66, pages 807 - 815 | - HENDERSON et al., Immun., (19910000), vol. 73, pages 316 - 321 | - BIERER et al., Curr. Opin. Immun., (19930000), vol. 5, pages 763 - 773 | - BERG et al., Transplant Proc., (19980000), vol. 30, no. 8, pages 3975 - 3977 | - GARLAND et al., J. Immunol Meth., (19990000), vol. 227, no. 1-2, pages 53 - 63 | - ERTL et al., Cancer Res, (20110000), vol. 71, pages 3175 - 81 | - JUNGHANS, Journal of Translational Medicine, (20100000), vol. 8, page 55 | - KIMVARKI, Glycoconj J, (19970000), vol. 14, pages 569 - 576 | - HAKOMORI, PNAS USA, (20020000), vol. 99, pages 10231 - 10233 | - KANEDA et al., J Biol Chem, (20020000), vol. 277, pages 16928 - 16935 | - BARRETT et al., Ann Rev Med, (20140000), vol. 65, pages 333 - 347 |